Loading…
← CockpitCompetitor Analysis › AMS.L Advanced Medical Solutions Group plcOpen in the cockpit ↗

Advanced Medical Solutions Group plcAMS.LCompetitor analysis, valuation and peers

United Kingdom · GBP·Health Care›Medical Specialties
Momentum strong 73
Mkt cap
$811M
US dollars, full cap
Free float
96%
of shares outstanding
$/day
$3.90M
20-day average traded
Fwd P/E
20.7×
forward earnings
ROIC−WACC
-2.8 pp
WACC 9.5%
Hurdle
-1 pp
Req g minus delivered
Next earnings
119 days
17 Mar 2027
Close · GBP£283.00
1D0.0%
1W0.0%
1M+0.3%
3M+0.5%
6M+27.2%
YTD+29.8%
1Y+35.1%
ATR %0.3%
52w lowhigh0.5% off high

What Advanced Medical Solutions does

Employees: 1,800

Advanced Medical Solutions at a glance

Size Advanced Medical Solutions (AMS.L) is a United Kingdom Health Care company (Medical Specialties) with a market value of $811M, the 237th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £283.00 on 18 Nov 2026.

Performance Over six months the shares gained 27.2%, against -15.2% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 7th highest of 21 in its peer set.

Growth Revenue grew 6.0% over the last twelve months (peer median +7.3%); the operating margin is 12.5% (peer median 9.4%).

Valuation It trades at 20.7× forward earnings against a peer median of 19.9× (5th most expensive of 13).

Price implies For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.8 points below its cost of capital (9.5% WACC).

Next results Next results expected around 17 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026AMS.L 133Peer median 86
Six months, rebased to 100: Advanced Medical Solutions against the median of its 20 peers (local-currency closes).

Advanced Medical Solutions financials

Reported figures in GBP; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue£234M£229M£178M£126M£124M
Revenue growth—+29%+41%+2%—
Gross profit£112M£109M£82.8M£63.7M£68.6M
EBITDA£51.1M£48.5M£37.7M£30.7M£34.9M
Net income£3.68M£9.95M£7.09M£15.9M£20.4M
Free cash flow£7.95M£21.4M£12.7M£10.9M£23.3M
Capital expenditure£18.0M£12.6M£8.74M£9.85M£9.96M
Total debtn/a£81.5M£86.6M£9.14M£9.75M

Quarterly statements and history in the cockpit →

Advanced Medical Solutions competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%-20%-10%0%+10%MCAP096530688068688805KIDS1187SETL603367BBNX3600MLABCTKB1302VREX2190301602688656002658300463AMS.L6-month return →1-month return →
Up and to the right = strong over both horizons. Advanced Medical Solutions is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×MCAP09653011876033673600MLAB13022190688656002658300463AMS.LRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Advanced Medical Solutions is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%MCAP09653068880511876033673600MLAB13022190301602688656002658300463AMS.LGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Advanced Medical Solutions is the large dot.

Advanced Medical Solutions competitors and peer comparison

How Advanced Medical Solutions compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Advanced Medical Solutions against its 20 peers (data as of 18 Nov 2026)
MeasureAMS.LPeer medianRank in peer set
1-month return+0.3%-5.1%7th highest of 21
6-month return+27.2%-15.2%7th highest of 21
Distance from 52-week high-0.5%-39.8%highest of 21
Revenue growth (TTM)+6.0%+7.3%10th lowest of 21
Operating margin12.5%9.4%8th highest of 21
Forward P/E20.7×19.9×5th most expensive of 13
Growth the price implies (Req g, 7 yrs)20.0%7.9%4th most demanding of 14
Growth delivered (Del g)+21.4%+11.3%2nd highest of 14
Hurdle (Req g minus delivered)-1.4 pp+6.5 pp7th least demanding of 14
ROIC minus cost of capital-2.8 pp-1.3 pp9th lowest of 21
EV / EBITDA13.5×14.3×5th cheapest of 9
Net debt / EBITDA1.4×0.1×4th most indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Advanced Medical Solutions AMS.LUnited Kingdom$811M+27%+6%12%20.7×20.0%+21.4%
MedCap MCAP.STSweden$811M-4%+17%15%25.8×2.7%+20.9%
Seegene 096530.KSSouth Korea$808M-26%+13%13%20.0×-6.7%-15.9%
Beijing Hotgen Biotech 688068.SSChina$815M-37%+8%-94%n/an/an/a
Ningbo Jansen Superconducting Technologies 688805.SSChina$818M-36%+36%16%n/a35.6%+17.1%
OrthoPediatrics KIDSUnited States$826M+71%+16%-8%n/an/an/a
Cofoe Medical Technology 1187.HKHong Kong$836M-11%+40%10%13.1×-6.4%+6.6%
Standard Engineering Technology SETL.NSIndia$783M+168%+45%14%n/an/an/a
Cisen Pharmaceutical 603367.SSChina$843M-15%-6%8%7.9×-14.6%-1.3%
Beta Bionics BBNXUnited States$779M+42%+44%-73%n/an/an/a
Modern Dental 3600.HKHong Kong$844M+24%+12%22%8.5×-7.1%+11.3%
Mesa Laboratories MLABUnited States$775M+33%+2%10%11.5×21.3%+13.2%
Cytek Biosciences CTKBUnited States$774M+57%+6%-21%n/an/an/a
LifeTech Scientific 1302.HKHong Kong$771M-30%+1%12%19.8×9.6%+15.5%
Varex Imaging VREXUnited States$771M+79%+5%8%19.9×n/an/a
Zylox-Tonbridge Medical Technology 2190.HKHong Kong$768M-16%+39%25%14.4×3.8%+105.8%
Shantou Institute of Ultrasonic Instruments 301602.SZChina$858M-25%+4%30%n/a11.1%+4.6%
HOB Biotech 688656.SSChina$858M-33%+6%7%166.9×37.6%+12.4%
Beijing SDL Technology 002658.SZChina$864M-34%-13%9%22.4×16.8%+2.9%
Maccura Biotechnology 300463.SZChina$756M-18%-1%-4%421.0×7.9%-10.2%
Tinavi Medical Technologies 688277.SSChina$872M-36%-2%-59%n/an/an/a

Questions

Which companies are Advanced Medical Solutions's closest peers?
The cockpit's peer set: MedCap (MCAP.ST), Seegene (096530.KS), Beijing Hotgen Biotech (688068.SS), Ningbo Jansen Superconducting Technologies (688805.SS), OrthoPediatrics (KIDS), Cofoe Medical Technology (1187.HK), Standard Engineering Technology (SETL.NS), Cisen Pharmaceutical (603367.SS).
Is Advanced Medical Solutions expensive compared with its peers?
On forward p/e it trades at 20.7× against a peer median of 19.9×, 5th most expensive of 13 in its peer set. For today's price to make sense, revenue must grow about 20% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Advanced Medical Solutions stock performed?
Over six months to 18 Nov 2026 the shares returned +27.2% against -15.2% for the median peer; over one year +35.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.